Your browser doesn't support javascript.
loading
Exposure to the antimicrobial peptide LL-37 produces dendritic cells optimized for immunotherapy.
Findlay, Emily Gwyer; Currie, Andrew J; Zhang, Ailiang; Ovciarikova, Jana; Young, Lisa; Stevens, Holly; McHugh, Brian J; Canel, Marta; Gray, Mohini; Milling, Simon W F; Campbell, John D M; Savill, John; Serrels, Alan; Davidson, Donald J.
Afiliação
  • Findlay EG; University of Edinburgh Centre for Inflammation Research, Queen's Medical Research Institute, Edinburgh, UK.
  • Currie AJ; School of Veterinary and Life Sciences, Murdoch University, Perth, Western Australia, Australia.
  • Zhang A; University of Edinburgh Centre for Inflammation Research, Queen's Medical Research Institute, Edinburgh, UK.
  • Ovciarikova J; University of Edinburgh Centre for Inflammation Research, Queen's Medical Research Institute, Edinburgh, UK.
  • Young L; University of Edinburgh Centre for Inflammation Research, Queen's Medical Research Institute, Edinburgh, UK.
  • Stevens H; University of Edinburgh Centre for Inflammation Research, Queen's Medical Research Institute, Edinburgh, UK.
  • McHugh BJ; University of Edinburgh Centre for Inflammation Research, Queen's Medical Research Institute, Edinburgh, UK.
  • Canel M; University of Edinburgh Centre for Inflammation Research, Queen's Medical Research Institute, Edinburgh, UK.
  • Gray M; University of Edinburgh Centre for Inflammation Research, Queen's Medical Research Institute, Edinburgh, UK.
  • Milling SWF; Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, UK.
  • Campbell JDM; Scottish National Blood Transfusion Service, Heriot Watt Research Park, Edinburgh, UK.
  • Savill J; University of Edinburgh Centre for Inflammation Research, Queen's Medical Research Institute, Edinburgh, UK.
  • Serrels A; University of Edinburgh Centre for Inflammation Research, Queen's Medical Research Institute, Edinburgh, UK.
  • Davidson DJ; University of Edinburgh Centre for Inflammation Research, Queen's Medical Research Institute, Edinburgh, UK.
Oncoimmunology ; 8(8): 1608106, 2019.
Article em En | MEDLINE | ID: mdl-31413918

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Ano de publicação: 2019 Tipo de documento: Article